Hangzhou Coco Healthcare Products Co.Ltd.

301009 · SHE · Consumer Defensive / Household & Personal Products

8.20CNY-0.15 (-1.80%)

Price History

Full chart

Market Stats

Previous Close8.35

Open8.40

Day Range8.11 – 8.42

52-Week Range7.86 – 14.94

Volume2.01M

Market Cap2.51B

P/E (TTM)0.00

Forward P/E0.00

EPS0.00

Dividend Yield1.30%

Beta0.47

50-Day Avg8.97

200-Day Avg10.76

About

Hangzhou Coco Healthcare Products Co.,Ltd. engages in the research, development, production, and sale of baby care, adult incontinence, and feminine and pet hygiene products in China and internationally. It offers adult incontinence products, including adult diapers, adult pull-up pants, nursing pads, maternity towels, menstrual pants, absorbent towels, and other products under the Reliable, Absorbent Treasure, and Anhushi brands. The company was formerly known as Hangzhou Qiaozi Paper Industry Co.,Ltd. and changed its name to Hangzhou Coco Healthcare Products Co.,Ltd. in December 2011. Hangzhou Coco Healthcare Products Co.,Ltd. was incorporated in 2001 and is headquartered in Hangzhou, China.

Company Details

SectorConsumer Defensive
IndustryHousehold & Personal Products
CEOMr. Liwei Jin
Employees756
HeadquartersChengxi Industrial Park, Hangzhou, China, 311300, China
Websitehttps://www.cocohealthcare.com

Leadership

Mr. Liwei JinCEO & Chairman of the Board · b. 1970
Ms. Chaonan LiDeputy GM & Financial Director · b. 1982
Ms. Zhongying ZhouDeputy GM & Director · b. 1968
Mr. Xiang Ting WangDeputy GM & Board Secretary · b. 1975
Jianjian DingAccounting Supervisor

Financials

Income Statement

Currency: CNY	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	786.94M	906.24M	1.17B	1.64B	1.19B	1.19B	1.08B	1.08B	1.15B
Growth (%)	-	+15.16%	+29.52%	+39.31%	-27.44%	-0.01%	-8.83%	-0.27%	+6.65%
Cost of Revenue	564.13M	675.83M	858.20M	1.18B	973.16M	1.04B	900.27M	866.70M	874.26M
Gross Profit	222.81M	230.41M	315.53M	452.95M	213.25M	143.63M	181.22M	211.84M	275.96M
Gross Margin	28.31%	25.43%	26.88%	27.70%	17.97%	12.11%	16.76%	19.64%	23.99%
Operating Expense	172.69M	164.22M	207.58M	197.56M	167.94M	199.10M	160.98M	180.82M	240.39M
Operating Income	50.12M	66.20M	107.95M	255.39M	45.30M	-55.47M	20.23M	31.02M	35.57M
Operating Margin	6.37%	7.30%	9.20%	15.62%	3.82%	-4.68%	1.87%	2.88%	3.09%
EBITDA	85.01M	100.90M	142.30M	297.81M	93.07M	4.50M	74.60M	88.11M	103.79M
EBITDA Margin	10.80%	11.13%	12.12%	18.21%	7.84%	0.38%	6.90%	8.17%	9.02%
Net Income	41.86M	59.68M	87.45M	214.01M	39.75M	-43.13M	20.18M	31.17M	36.12M
Net Income Margin	5.32%	6.59%	7.45%	13.09%	3.35%	-3.64%	1.87%	2.89%	3.14%
R&D	34.62M	34.16M	44.19M	58.84M	49.27M	50.98M	44.11M	45.04M	48.36M
R&D as % of Total Revenue	4.40%	3.77%	3.77%	3.60%	4.15%	4.30%	4.08%	4.18%	4.20%
Interest Expense	1.75M	1.66M	2.01M	3.39M	1.98M	1.14M	1.42M	726.35K	2.26M
Interest Expense % of Total Revenue	0.22%	0.18%	0.17%	0.21%	0.17%	0.10%	0.13%	0.07%	0.20%

Balance Sheet

Currency: CNY	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	957.14M	996.27M	1.07B	1.49B	2.09B	1.95B	1.99B	2.09B	2.18B
Total Liabilities	484.59M	460.64M	613.89M	812.42M	578.59M	516.88M	542.40M	678.06M	756.38M
Total Equity	430.97M	482.82M	399.01M	613.43M	1.41B	1.35B	1.37B	1.33B	1.34B
Cash	244.11M	230.98M	200.39M	339.25M	884.04M	689.46M	863.06M	613.70M	811.16M
Total Debt	50.00M	11.00M	40.85M	99.18M	6.61M	4.64M	18.05M	108.31M	-
Net Debt	-194.11M	-219.98M	-159.54M	-240.07M	-877.44M	-684.82M	-845.01M	-505.38M	-

Cash Flow

Currency: CNY	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	109.74M	114.26M	223.33M	395.86M	50.53M	-37.20M	227.70M	52.44M	126.76M
Investing Cash Flow	-51.82M	-90.19M	-135.72M	-311.47M	-114.92M	-112.14M	-73.25M	-328.47M	-
Financing Cash Flow	-36.61M	-40.53M	-137.66M	28.47M	683.82M	-49.87M	396.75K	27.07M	-
Capital Expenditure	77.41M	89.78M	125.86M	220.71M	240.45M	116.40M	66.01M	75.35M	39.88M
Free Cash Flow	32.33M	24.49M	97.46M	175.15M	-189.92M	-153.60M	161.69M	-22.91M	86.88M
Dividends Paid	46.61M	1.53M	180.47M	23.63M	882.68K	19.03M	-	20.14M	20.23M
FCF to OCF	29.46%	21.43%	43.64%	44.25%	-375.90%	412.87%	71.01%	-43.69%	68.54%
Dividend Paid to FCF	144.18%	6.23%	185.18%	13.49%	-0.46%	-12.39%	-	-87.89%	23.28%

Earnings

Report Date	Jun 30, 2021	Sep 30, 2021	Apr 22, 2022	Aug 26, 2022	Oct 26, 2022	Apr 27, 2023	Aug 28, 2023	Oct 25, 2023	Apr 26, 2024	Aug 25, 2024	Oct 24, 2024	Apr 27, 2025	Aug 25, 2025	Oct 28, 2025	Apr 27, 2026	Aug 31, 2026
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	0.10	0.01	0.01	-0.01	0.05	-0.21	0.04	0.02	0.07	0.02	-0.00	0.03	0.04	-0.00	0.01	-0.04
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	After-hours	Pre-market	After-hours	Pre-market	Pre-market	After-hours	After-hours	After-hours	Pre-market	Pre-market	-	-	-	-

Key Statistics & Ratios

Market Cap2.51B

Enterprise Value1.78B

Trailing P/E0.00

Forward P/E0.00

Price / Sales2.12

Price / Book1.92

EPS0.00

Book Value4.89

Revenue (TTM)1.18B

Gross Profit (TTM)267.85M

EBITDA61.34M

Profit Margin-0.01%

Operating Margin-3.01%

Return on Equity0.15%

Return on Assets0.10%

Shares Outstanding271.86M

Shares Float88.74M

Beta0.47

Dividend Yield1.30%

Dividend Rate0.12

Payout Ratio2500.00%

Dividends

20261×

0.12Jun 25, 2026

20251×

0.07Jul 4, 2025

20241×

0.07Jul 19, 2024

20221×

0.07May 26, 2022